• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down3.39% Nasdaq Down4.12%

    More On OXI.PA



    News & Info


    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates


    • Major Holders
    • Insider Transactions
    • Insider Roster


    OXIS International, Inc. (OXI.PA)

    0.44 0.00(0.00%) Jun 24, 10:29AM EDT
    ProfileGet Profile for:
    OXIS International, Inc.
    100 South Ashley Drive
    Suite 600
    Tampa, FL 33602
    United States - Map
    Phone: 800-304-9888
    Website: http://www.oxis.com

    Index Membership:N/A
    Industry:Medical Laboratories & Research
    Full Time Employees:2

    Business Summary 

    OXIS International, Inc., through its subsidiary, Oxis Biotech, Inc., discovers, develops, and commercializes therapeutics from its proprietary product platform in various disease areas in the United States. The company is developing drugs focused on the treatment of cancer. Its lead drug candidates include OXS-2175, a small molecule therapeutic candidate targeting the treatment of triple-negative breast cancer; OXS-4235, a small molecule therapeutic candidate to treat multiple myeloma and associated osteolytic lesion; and OXS-1550, a bispecific scFv recombinant fusion protein-drug conjugate that targets cancer cells expressing the CD19 receptor or CD22 receptor, or both receptors. The company was formerly known as DDI Pharmaceuticals, Inc. and changed its name to Oxis International, Inc. in 1994. Oxis International, Inc. was founded in 1965 and is based in Tampa, Florida.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on OXIS International, Inc.

    Key Executives 
    Mr. Anthony J. Cataldo , 65
    Chairman and Chief Exec. Officer
    Mr. Steven W. Weldon MBA, CPA, 40
    Pres, Chief Financial Officer, Chief Accounting Officer and Director
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in EUR.